{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:04:24Z","timestamp":1790744664043,"version":"4.1.0"},"reference-count":16,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.3892\/mmr.2016.4864","type":"journal-article","created":{"date-parts":[[2016,2,4]],"date-time":"2016-02-04T07:55:23Z","timestamp":1454572523000},"page":"2724-2728","source":"Crossref","is-referenced-by-count":7,"title":["Enhancer of zeste homolog 2 depletion arrests the proliferation of hepatoblastoma cells"],"prefix":"10.3892","volume":"13","author":[{"given":"YUE","family":"WANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YONGTAO","family":"XIAO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KAI","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHENG","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MIN","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZHIXIANG","family":"WU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YEMING","family":"WU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,2,4]]},"reference":[{"key":"key20180108023449_b1-mmr-13-03-2724","first-page":"539","article-title":"Tumors of the liver in early infancy: Hepatoblastoma","volume":"71","author":"Yang","year":"1972","journal-title":"Mich Med"},{"key":"key20180108023449_b2-mmr-13-03-2724","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/mpo.10171","article-title":"Hepatoblastoma: Assessment of criteria for histologic classification","volume":"39","author":"Rowland","year":"2002","journal-title":"Med Pediatr Oncol"},{"key":"key20180108023449_b3-mmr-13-03-2724","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.2741\/e492","article-title":"Treatment of hepatoblastoma: The North American cooperative group experience","volume":"4","author":"Malogolowkin","year":"2012","journal-title":"Front Biosci (Elite Ed)"},{"key":"key20180108023449_b4-mmr-13-03-2724","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/138920107780487456","article-title":"Drug resistance in hepatoblastoma","volume":"8","author":"Warmann","year":"2007","journal-title":"Curr Pharm Biotechnol"},{"key":"key20180108023449_b5-mmr-13-03-2724","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1076997","article-title":"Role of histone H3 lysine 27 methylation in Polycomb-group silencing","volume":"298","author":"Cao","year":"2002","journal-title":"Science"},{"key":"key20180108023449_b6-mmr-13-03-2724","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.biocel.2011.01.005","article-title":"Enhancer of zeste homolog 2: A potential target for tumor therapy","volume":"43","author":"Xiao","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"key":"key20180108023449_b7-mmr-13-03-2724","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nature01075","article-title":"The polycomb group protein EZH2 is involved in progression of prostate cancer","volume":"419","author":"Varambally","year":"2002","journal-title":"Nature"},{"key":"key20180108023449_b8-mmr-13-03-2724","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/hep.21668","article-title":"Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin","volume":"46","author":"Chen","year":"2007","journal-title":"Hepatology"},{"key":"key20180108023449_b9-mmr-13-03-2724","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/gut.2010.231993","article-title":"EZH2 protein: A promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies","volume":"60","author":"Cai","year":"2011","journal-title":"Gut"},{"key":"key20180108023449_b10-mmr-13-03-2724","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1746-1596-7-86","article-title":"Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors","volume":"7","author":"Haj\u00f3si-Kalcakosz","year":"2012","journal-title":"Diagn Pathol"},{"key":"key20180108023449_b11-mmr-13-03-2724","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.humpath.2009.01.017","article-title":"Distinct expression of polycomb group proteins EZH2 and BMI1 in hepatocellular carcinoma","volume":"40","author":"Yonemitsu","year":"2009","journal-title":"Hum Pathol"},{"key":"key20180108023449_b12-mmr-13-03-2724","doi-asserted-by":"crossref","first-page":"6790","DOI":"10.1158\/1078-0432.CCR-08-1013","article-title":"Regulation of pancreatic tumor cell proliferation and chemoresistance by the histone methyltransferase enhancer of zeste homologue 2","volume":"14","author":"Ougolkov","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20180108023449_b13-mmr-13-03-2724","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1101\/gad.1499407","article-title":"pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene","volume":"21","author":"Kotake","year":"2007","journal-title":"Genes Dev"},{"key":"key20180108023449_b14-mmr-13-03-2724","doi-asserted-by":"crossref","first-page":"17324","DOI":"10.1074\/jbc.M800224200","article-title":"Enhancer of zeste homologue 2 (EZH2) down-regulates RUNX3 by increasing histone H3 methylation","volume":"283","author":"Fujii","year":"2008","journal-title":"J Biol Chem"},{"issue":"Suppl 3","key":"key20180108023449_b15-mmr-13-03-2724","doi-asserted-by":"crossref","first-page":"S667","DOI":"10.1245\/s10434-013-3135-y","article-title":"Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis","volume":"20","author":"Nakagawa","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"key20180108023449_b16-mmr-13-03-2724","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.bbrc.2012.05.035","article-title":"The enhancer of zeste homolog 2 (EZH2), a potential therapeutic target, is regulated by miR-101 in renal cancer cells","volume":"422","author":"Sakurai","year":"2012","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2016.4864\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T04:44:14Z","timestamp":1515386654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2016.4864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,4]]},"references-count":16,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,2,4]]},"published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.3892\/mmr.2016.4864"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2016.4864","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,4]]}}}